Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (1 ops.)
Latest filing published 30 Dec 2025 for Cogent Biosciences, Inc., €2.1M. Read the official filing
Filing timeline
BuySaleEvan Kearns
Insider track record
Disclosed buys
0
Disclosed sells
1
Signal history
No signal scores available.
Evan Kearns: trading record in brief
Evan Kearns discloses dealings in Cogent Biosciences, Inc. to SEC (Form 4). Between 17 December 2025 and 26 December 2025, the trades on record add up to 2 filings.
No open-market purchase appears, only 1 sale worth €2.1M. Outside the open market, there are 1 share grant.
The newest entry dates from 30 December 2025: an open-market sale of €2.1M, in Cogent Biosciences, Inc. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Evan Kearns
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations2 total
65,000 shares@ US$38.70100.0% of flowCommon StockSEC:0001193125-25-337052:0
40,000 shares0Common StockSEC:0001193125-25-326772:0
2 of 2 declarations
